HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Samuel K Houston Selected Research

beta Subunit Luteinizing Hormone

2/2012Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumors.
1/2012Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LH(BETA)T(AG) retinal tumors.
7/2011Regional and temporal differences in gene expression of LH(BETA)T(AG) retinoblastoma tumors.
1/2011Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LH(BETA)T(AG) retinoblastoma tumors.
12/2010Focal, periocular delivery of 2-deoxy-D-glucose as adjuvant to chemotherapy for treatment of advanced retinoblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Samuel K Houston Research Topics

Disease

9Neoplasms (Cancer)
05/2013 - 09/2010
7Retinoblastoma (Glioblastoma, Retinal)
04/2013 - 09/2010
5Retinal Neoplasms
05/2013 - 12/2010
4Hypoxia (Hypoxemia)
04/2013 - 12/2010
4Melanoma (Melanoma, Malignant)
01/2013 - 09/2011
4Uveal melanoma
01/2013 - 01/2012
3Macular Edema
01/2017 - 01/2013
3Macular Degeneration (Age-Related Maculopathy)
09/2015 - 01/2012
2Retinal Vein Occlusion
01/2017 - 10/2016
1Phototoxic Dermatitis (Phototoxicity)
01/2019
1Wounds and Injuries (Trauma)
06/2017
1Edema (Dropsy)
10/2016
1Retinal Perforations
05/2015
1Hyperthermia
04/2013
1Retinopathy of Prematurity (Retrolental Fibroplasia)
02/2013
1Disease Progression
02/2013
1Retinal Detachment (Retinal Detachments)
01/2013
1Neovascular Glaucoma
01/2012
1Angle-Closure Glaucoma (Glaucoma, Angle Closure)
01/2012
1Ocular Hypertension (Glaucoma, Suspect)
01/2012
1Retinal Diseases
01/2011
1Sclerosis
09/2010

Drug/Important Bio-Agent (IBA)

5beta Subunit Luteinizing HormoneIBA
02/2012 - 12/2010
4Bevacizumab (Avastin)FDA Link
10/2016 - 01/2012
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2016 - 01/2011
3Deoxyglucose (2 Deoxy D glucose)IBA
01/2012 - 12/2010
2Retinaldehyde (Retinal)IBA
01/2019 - 02/2013
2afliberceptIBA
01/2017 - 10/2016
2Iodine-125IBA
01/2013 - 01/2012
2Triamcinolone (Aristocort)FDA Link
01/2013 - 01/2012
2Carboplatin (JM8)FDA LinkGeneric
12/2010 - 09/2010
1Ranibizumab (Lucentis)FDA Link
10/2016
1microplasminIBA
05/2015
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
01/2013
1Hematoxylin (Haematoxylon)IBA
02/2012
1Eosine Yellowish-(YS) (Eosin)IBA
02/2012
1Protons (Proton)IBA
09/2011
1Oxygen (Dioxygen)IBA
07/2011
1anecortave acetateIBA
01/2011
1pimonidazoleIBA
12/2010
1Melphalan (Alkeran)FDA LinkGeneric
09/2010

Therapy/Procedure

7Therapeutics
09/2015 - 12/2010
5Drug Therapy (Chemotherapy)
04/2013 - 09/2010
5Brachytherapy
01/2013 - 01/2012
4Injections
01/2013 - 09/2010
3Vitrectomy
06/2017 - 01/2012
3Lasers (Laser)
05/2013 - 09/2010
2Radiotherapy
04/2013 - 01/2012
2Laser Therapy (Surgery, Laser)
02/2013 - 09/2010
2Aftercare (After-Treatment)
09/2011 - 12/2010
1Cautery
06/2017
1Traction
05/2015
1Intravitreal Injections
04/2013
1Phacoemulsification
01/2012
1Glaucoma Drainage Implants
01/2012
1Complementary Therapies (Alternative Medicine)
01/2011